CN100999493A - 一种喹诺酮主环化合物的合成方法 - Google Patents
一种喹诺酮主环化合物的合成方法 Download PDFInfo
- Publication number
- CN100999493A CN100999493A CN 200610155320 CN200610155320A CN100999493A CN 100999493 A CN100999493 A CN 100999493A CN 200610155320 CN200610155320 CN 200610155320 CN 200610155320 A CN200610155320 A CN 200610155320A CN 100999493 A CN100999493 A CN 100999493A
- Authority
- CN
- China
- Prior art keywords
- reaction
- substitution
- aroyl
- quinoline compound
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 9
- 150000001875 compounds Chemical class 0.000 title abstract description 13
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title abstract description 4
- 230000002194 synthesizing effect Effects 0.000 title 1
- -1 formyl acetate alkali metal salts Chemical class 0.000 claims abstract description 40
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- 150000001412 amines Chemical class 0.000 claims abstract description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 6
- 238000005576 amination reaction Methods 0.000 claims abstract description 6
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 6
- 238000005917 acylation reaction Methods 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 33
- 238000006467 substitution reaction Methods 0.000 claims description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 27
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000010189 synthetic method Methods 0.000 claims description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- QDHUQRBYCVAWEN-UHFFFAOYSA-N amino prop-2-enoate Chemical class NOC(=O)C=C QDHUQRBYCVAWEN-UHFFFAOYSA-N 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 claims description 11
- 235000019439 ethyl acetate Nutrition 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 150000002367 halogens Chemical group 0.000 claims description 8
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 claims description 7
- 125000004494 ethyl ester group Chemical group 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- KUHNQNUSGIAQLQ-UHFFFAOYSA-N ethyl 2-aminoprop-2-enoate Chemical compound CCOC(=O)C(N)=C KUHNQNUSGIAQLQ-UHFFFAOYSA-N 0.000 claims description 6
- BUBWTSJXUHKBBX-UHFFFAOYSA-N ethyl acetate;sodium Chemical compound [Na].CCOC(C)=O BUBWTSJXUHKBBX-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 150000004996 alkyl benzenes Chemical class 0.000 claims description 5
- 125000003435 aroyl group Chemical group 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- 229910005965 SO 2 Inorganic materials 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 230000003292 diminished effect Effects 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 239000012452 mother liquor Substances 0.000 claims description 4
- 239000012074 organic phase Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000007670 refining Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 238000010792 warming Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 239000002879 Lewis base Substances 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 150000007527 lewis bases Chemical group 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 claims description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 2
- 229940043232 butyl acetate Drugs 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims description 2
- 229960003923 gatifloxacin Drugs 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000004193 piperazinyl group Chemical group 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 abstract description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 229910000104 sodium hydride Inorganic materials 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000011734 sodium Substances 0.000 abstract description 2
- 239000012312 sodium hydride Substances 0.000 abstract description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 abstract 1
- 208000005623 Carcinogenesis Diseases 0.000 abstract 1
- 239000012267 brine Substances 0.000 abstract 1
- 230000036952 cancer formation Effects 0.000 abstract 1
- 231100000504 carcinogenesis Toxicity 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 abstract 1
- 238000001308 synthesis method Methods 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N N,N-Diethylethanamine Substances CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 150000007660 quinolones Chemical class 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- ZMPICCMPENQNFS-UHFFFAOYSA-N 2-fluoro-3-methoxybenzoyl chloride Chemical class COC1=CC=CC(C(Cl)=O)=C1F ZMPICCMPENQNFS-UHFFFAOYSA-N 0.000 description 1
- CFLBIADORGSMCX-UHFFFAOYSA-N 2h-1,4-benzoxazine-6-carboxylic acid Chemical compound O1CC=NC2=CC(C(=O)O)=CC=C21 CFLBIADORGSMCX-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610155320XA CN100516046C (zh) | 2006-12-19 | 2006-12-19 | 一种喹诺酮主环化合物的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610155320XA CN100516046C (zh) | 2006-12-19 | 2006-12-19 | 一种喹诺酮主环化合物的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN100999493A true CN100999493A (zh) | 2007-07-18 |
CN100516046C CN100516046C (zh) | 2009-07-22 |
Family
ID=38258329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610155320XA Active CN100516046C (zh) | 2006-12-19 | 2006-12-19 | 一种喹诺酮主环化合物的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100516046C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899044A (zh) * | 2010-08-16 | 2010-12-01 | 常州市勇毅生物药业有限公司 | 吉米沙星主环化合物的合成方法 |
CN103360310A (zh) * | 2012-04-06 | 2013-10-23 | 深圳信立泰药业股份有限公司 | 一种西他沙星中间体、西他沙星的制备方法和西他沙星药物组合物 |
CN104774178A (zh) * | 2015-02-02 | 2015-07-15 | 浙江科技学院 | 一种7-氯-1-乙基-6-氟-1,4-二氢-4-氧代喹啉-3-羧酸乙酯的制备方法 |
CN114716373A (zh) * | 2022-04-14 | 2022-07-08 | 内蒙古源宏精细化工有限公司 | 一种加替沙星环合酯的制备方法 |
-
2006
- 2006-12-19 CN CNB200610155320XA patent/CN100516046C/zh active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899044A (zh) * | 2010-08-16 | 2010-12-01 | 常州市勇毅生物药业有限公司 | 吉米沙星主环化合物的合成方法 |
CN101899044B (zh) * | 2010-08-16 | 2012-07-18 | 常州市勇毅生物药业有限公司 | 吉米沙星主环化合物的合成方法 |
CN103360310A (zh) * | 2012-04-06 | 2013-10-23 | 深圳信立泰药业股份有限公司 | 一种西他沙星中间体、西他沙星的制备方法和西他沙星药物组合物 |
CN104774178A (zh) * | 2015-02-02 | 2015-07-15 | 浙江科技学院 | 一种7-氯-1-乙基-6-氟-1,4-二氢-4-氧代喹啉-3-羧酸乙酯的制备方法 |
CN114716373A (zh) * | 2022-04-14 | 2022-07-08 | 内蒙古源宏精细化工有限公司 | 一种加替沙星环合酯的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100516046C (zh) | 2009-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101020658B (zh) | 喹诺酮主环化合物的合成方法 | |
CN101838238B (zh) | 一种喹诺酮主环化合物的合成方法 | |
JPS61112075A (ja) | チエニルピラゾロキノリン誘導体 | |
CN101607955B (zh) | 一种低残留硫辛酸的制备方法 | |
CN100516046C (zh) | 一种喹诺酮主环化合物的合成方法 | |
CA2958625A1 (en) | Crystal of pyrrole derivative and method for producing the same | |
CN106117148B (zh) | 一种洛匹那韦的制备和纯化工艺 | |
CN101648960B (zh) | 氧氟沙星的制备方法 | |
IE840443L (en) | Quinolonecarboxylic acids | |
CN112538079A (zh) | 一种香豆素类衍生物及其合成方法与应用 | |
CN102584860B (zh) | 含吲哚结构的螺杂环化合物及其制备方法 | |
EP3029028B1 (en) | Novel method for synthesizing key intermediate of apixaban | |
CN109988167A (zh) | 一种他达拉非的制备方法 | |
TWI676625B (zh) | 磺醯胺類衍生物、其製備方法及其在醫藥上的用途 | |
CN110724094B (zh) | 一种喹啉类化合物及其合成方法 | |
CN116003309A (zh) | 一类酰肼类化合物、其制备方法及其应用 | |
CN113557236B (zh) | 一种双功能免疫调节剂及其在药学上可接受的盐、药物组合物 | |
Kakuno et al. | Utilization of Chlobenthiazone and Benazolin-ethyl as 4-Substituted 2 (3H)-Benzothiazol-2-one Scaffolds | |
CN110078655B (zh) | 一种光催化制备吲哚类化合物的方法 | |
CN102442997B (zh) | 一类喹啉衍生物、其制备方法、中间体及其应用 | |
RU2455289C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ 5,6-ДИГИДРО-7Н-ПИРРОЛО[1,2-d][1,4] БЕНЗОДИАЗЕПИН-6-ОНА | |
CA2704649C (en) | Tetracyclic dipyrano-coumarin compounds with anti-hiv and anti-mycobacterium tuberculosis activities | |
CN100545148C (zh) | 一种抗良性前列腺肥大药物坦索罗辛之合成方法 | |
CN103265559A (zh) | 取代三环苯醌类化合物及其制备方法与应用 | |
AU2019291703B2 (en) | Compound and use thereof in synthesis of brivaracetam intermediate and crude drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hangzhou Great Forest Biomedical Ltd. Assignor: Gu Haining Contract fulfillment period: 2009.8.7 to 2026.12.18 contract change Contract record no.: 2009330001969 Denomination of invention: Synthesizing process of quinolone main cycle compound Granted publication date: 20090722 License type: General permission Record date: 2009.8.17 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: COMMON LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.8.7 TO 2026.12.18; CHANGE OF CONTRACT Name of requester: HANGZHOU GREAT FOREST BIOMEDICAL CO., LTD. Effective date: 20090817 |
|
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU GREAT FOREST BIOMEDICAL LTD. Free format text: FORMER OWNER: GU HAINING Effective date: 20110130 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310028 ROOM 307, WEST TEACHING BUILDING 6, NO.148, TIANMUSHAN ROAD, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 310028 ROOM 603, WEST TEACHING BUILDING 6, NO.148, TIANMUSHAN ROAD, HANGZHOU CITY, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110130 Address after: 603 room 310028, West six teaching building, No. 148 Tianmu Road, Zhejiang, Hangzhou Patentee after: Hangzhou Great Forest Biomedical Ltd. Address before: 307 room 310028, West six teaching building, No. 148 Tianmu Road, Zhejiang, Hangzhou Patentee before: Gu Haining |
|
ASS | Succession or assignment of patent right |
Owner name: GU HAINING Free format text: FORMER OWNER: HANGZHOU GREAT FOREST BIOMEDICAL LTD. Effective date: 20130306 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310028 HANGZHOU, ZHEJIANG PROVINCE TO: 311121 HANGZHOU, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130306 Address after: Hangzhou City, Zhejiang province 311121 Yuhang District No. 1378 West Street warehouse before building 1 building F room 909-913 Patentee after: Gu Haining Address before: 603 room 310028, West six teaching building, No. 148 Tianmu Road, Zhejiang, Hangzhou Patentee before: Hangzhou Great Forest Biomedical Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG BENLI CHEMICAL CO., LTD. Free format text: FORMER OWNER: GU HAINING Effective date: 20141029 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 311121 HANGZHOU, ZHEJIANG PROVINCE TO: 317016 TAIZHOU, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141029 Address after: 317016 Zhejiang City, Linhai City, Du Bridge Town Medical Park Patentee after: Zhejiang Benli Chemical Co., Ltd. Address before: Hangzhou District of Yuhang Zhejiang province 311121 Street warehouse before West No. 1378 Building 1 building F room 909-913 Patentee before: Gu Haining |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 15 No. 317016 Zhejiang Province coastal Toumen Port District East Sixth Avenue Patentee after: ZHEJIANG BENLI CHEMICAL CO., LTD. Address before: 317016 Zhejiang City, Linhai City, Du Bridge Town Medical Park Patentee before: Zhejiang Benli Chemical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170511 Address after: 213000 Jiangsu city in Changzhou Province, north riverside town of Port Road No. 5 Patentee after: JIANGSU YONGDA PHARMACEUTICAL CO., LTD. Address before: 15 No. 317016 Zhejiang Province coastal Toumen Port District East Sixth Avenue Patentee before: ZHEJIANG BENLI CHEMICAL CO., LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180502 Address after: 317016 No. 15 Donghai Sixth Avenue, Taizhou, Zhejiang. Patentee after: ZHEJIANG BENLI CHEMICAL CO., LTD. Address before: 213000 No. 5 North Road, Chun Jiang Town, Xinbei District, Changzhou, Jiangsu Patentee before: JIANGSU YONGDA PHARMACEUTICAL CO., LTD. |
|
TR01 | Transfer of patent right |